We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+4.36%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$13.8B
AUM Growth
+$1.02B
(+8%)
Cap. Flow
+$618M
Cap. Flow
% of AUM
4.47%
Top 10 Holdings %
Top 10 Hldgs %
12.42%
Holding
2,126
New
119
Increased
1,428
Reduced
493
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$22.5M |
| 2 |
Walmart Inc
WMT
|
+$16.8M |
| 3 |
IBM
IBM
|
+$16.1M |
| 4 |
Johnson & Johnson
JNJ
|
+$15.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$26.9M |
| 2 |
DEG
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
|
+$14.8M |
| 3 |
NJ
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
|
+$10.2M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$8.5M |
| 5 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$6.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.94% |
| 4 | Consumer Staples | 9.08% |
| 5 | Industrials | 8.6% |
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q3 2016 Portfolio in Review
As of Q3 2016, Aperio Group held 2,126 positions worth $13.8B, up 8% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $618M of net new capital in Q3 2016, opening 119 new positions and adding to 1,428 existing holdings. Its largest new stake was Fortive: 345,212 shares worth $11.1M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.5M trimmed.
- Aperio Group's largest Q3 2016 buy was Fortive: 345,212 shares worth $11.1M.
- Aperio Group added most to Apple in Q3 2016, an estimated $22.5M increase.
- Aperio Group's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $8.5M.
- Aperio Group fully exited EMC CORPORATION in Q3 2016, selling an estimated $26.9M.
- Aperio Group's ten largest holdings make up 12% of its $13.8B portfolio in Q3 2016.
- Aperio Group opened 119 new positions and closed 63 in Q3 2016.
- Aperio Group's portfolio value rose 8% quarter-over-quarter to $13.8B.
Based on Aperio Group's 13F filing for Q3 2016, filed 2 Nov 2016.